Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder

Inclusion Criteria: * Participated in the study DIEF003523.1, received sham "placebo" TMS and achieved \< 50% improvement in HARS at 3 month follow-up. * Fluency in English * Capacity to understand the nature of the study and willingness to sign informed consent form Exclusion Criteria: * History of epilepsy or head trauma (LOC \> 5 minutes) within the past 6 months * Lifetime history of increased intracranial pressure, seizure disorder, stroke, brain tumor, multiple sclerosis, or brain surgery * A review of patient medications by the study physician indicates an increased risk of seizure * An active autoimmune, endocrine, viral, or vascular disorder affecting the brain; any unstable cardiac disease; hypertension; or severe renal or liver insufficiency * Substance use disorder or PTSD within the past 6 months * Lifetime bipolar disorder, obsessive-compulsive disorder (OCD), psychotic disorder, mental retardation, or pervasive developmental disorder * Any psychotic features, including dementia or delirium * Concurrent psychotherapy and unwillingness to discontinue * Medication change within the past 4 weeks * Current serious suicidal or homicidal ideation, and/or serious suicidal attempt within the past 6 months * Serious, unstable, or terminal medical condition or clinically judged too psychiatrically unstable to participate in the study * Any contraindication for participation in MRI scan